GLUE
Monte Rosa Therapeutics, Inc.
+0.04 (+0.28%)12.69USD532K成交股數1.1B市值–本益比(近四季)37.7股價營收比-61.3%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 9.0M-89% | 4.2M-93% | 12.8M+39% | 23.2M+394% | 84.9M+7882% | 60.6M | 9.2M | 4.7M | 1.1M | 0.00 | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 48.0M | 44.1M | 36.7M | 30.7M | 32.2M | 38.9M | 27.6M | 28.1M | 27.0M | 28.3M | 29.1M | 26.8M |
| 銷售管理費用 | 10.1M | 10.2M | 9.1M | 8.1M | 8.7M | 8.8M | 8.1M | 9.3M | 9.0M | 8.7M | 8.1M | 7.5M |
| 營業利益 | −49.1M-212% | −50.0M-485% | −33.0M+24% | −15.6M-52% | 44.0M-226% | 13.0M-135% | −26.5M-29% | −32.6M-5% | −34.9M | −37.0M | −37.2M | −34.3M |
| 營業利益率 | -547.8% | -1,188.5% | -258.3% | -67.1% | 51.9% | 21.4% | -287.8% | -695.3% | -3,284.5% | – | – | – |
| 稅後淨利 | −43.4M-193% | −44.5M-431% | −27.1M+14% | −12.3M-59% | 46.9M-247% | 13.4M-139% | −23.9M-32% | −30.3M-5% | −32.0M | −34.9M | −35.2M | −32.0M |
| 淨利率 | -483.9% | -1,057.1% | -212.1% | -53.0% | 55.2% | 22.2% | -258.9% | -645.6% | -3,004.5% | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | 101M | 99.9M | 82.4M | 82.2M | 83.0M | 73.9M | 82.0M | 71.2M | 60.2M | 49.8M | 49.4M | 49.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 90.1M | 160M | 208M | 69.4M | 78.5M | 224M | 126M | 109M | 99.8M | 59.1M | 47.0M | 51.8M |
| 應收帳款 | – | – | – | – | – | – | – | 9.0M | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 691M | 736M | 460M | 360M | 393M | 439M | 315M | 344M | 267M | 252M | 279M | 309M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 204M | 215M | 214M | 91.5M | 118M | 216M | 110M | 119M | 114M | 67.6M | 65.0M | 65.3M |
| 股東權益 | 487M | 522M | 246M | 268M | 275M | 223M | 205M | 225M | 153M | 185M | 214M | 244M |
| 負債比 | 29.5% | 29.1% | 46.5% | 25.4% | 30.0% | 49.2% | 34.8% | 34.7% | 42.8% | 26.8% | 23.3% | 21.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −37.4M | – | – | −45.5M+19% | – | – | – | −38.2M | – | – | −23.4M |
| 資本支出 | – | 1.9M | – | – | 1.6M | – | – | – | 1.4M | – | – | 9.2M |
| 自由現金流 | – | −39.2M | – | – | −47.1M+19% | – | – | – | −39.5M | – | – | −32.6M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | 0.00 | – | – | 0.00 | – | – | – | 0.00 | – | – | 0.00 |
| 自由現金流率 | – | -932.0% | – | – | -55.4% | – | – | – | -3,717.0% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 124M | +63.5% | −38.6M | -31.2% | – | −27.5M |
| FY2024 | 75.6M | – | −72.7M | -96.1% | – | 38.0M |
| FY2023 | 0.00 | – | −135M | –% | – | −62.8M |
| FY2022 | – | – | −109M | –% | – | −105M |
| FY2021 | – | – | −74.0M | –% | -2.96 | −69.1M |
| FY2020 | – | – | −35.9M | –% | -23.65 | −26.4M |